Seeing Is Believing
Currently out of the existing stock ratings of Elmar Kraus, 7 are a BUY (53.85%), 6 are a HOLD (46.15%).
Analyst Elmar Kraus works at DZ BANK with a stock forecast success ratio of 68.33% fulfilled within 283.6 days on average.
Elmar Kraus’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LLY, Eli Lilly and Company at 21-Feb-2024.
Analyst best performing recommendations are on BIIB (BIOGEN).
The best stock recommendation documented was for LLY (ELI LILLY AND COMPANY) at 1/21/2022. The price target of $291 was fulfilled within 75 days with a profit of $53.95 (22.76%) receiving and performance score of 3.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
270
$52.49 (24.13%)
270
6 days ago
24/37 (64.86%)
$61.1 (29.25%)
326
Hold
200
$-17.51 (-8.05%)
215
10 days ago
20/23 (86.96%)
$-2.46 (-1.22%)
221
Buy
294
$76.49 (35.17%)
305
11 days ago
7/22 (31.82%)
$92.01 (45.55%)
255
Hold
214
$-3.51 (-1.61%)
250
18 days ago
4/15 (26.67%)
$21.84 (11.37%)
68
Hold
213
$-4.51 (-2.07%)
239
18 days ago
22/24 (91.67%)
$20.84 (10.85%)
139
Which stock is Elmar Kraus is most bullish on?
Which stock is Elmar Kraus is most reserved on?
What Year was the first public recommendation made by Elmar Kraus?